Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium.
about
Clinical lung xenotransplantation--what donor genetic modifications may be necessary?Targeting tumor vasculature with an oncolytic virus.Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection.Immunobiology of liver xenotransplantation.Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells.Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expressionp75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.The interface between coagulation and immunity.Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting.Xenotransplantation: the next generation of engineered animalsProtease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo.Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss.Inhibition of Angiopoietin-2 Production by Myofibrocytes Inhibits Neointimal Hyperplasia After Endoluminal Injury in MiceFibrocytes mediate intimal hyperplasia post-vascular injury and are regulated by two tissue factor-dependent mechanismsPostinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins
P2860
Q26823663-440CBB6D-1128-4486-A3F2-644365ECF915Q30500348-A7559F07-196F-4119-997A-E54226F6395DQ33291121-EA80FAE8-954A-474B-93C6-4778A8C5D912Q33403888-3F02CFC8-0194-41E4-9A2A-401D0842AE48Q34040373-2354B1A8-64C1-4CB3-BF62-607424DF1186Q35823171-0EF63D18-7E8A-4070-B234-FA90D86862E3Q36118647-3F5A99C7-29E3-4BCB-BB12-615CA28A5E15Q36710224-045FA18A-0478-43AA-9710-24283ACE9DF1Q37105092-A179B473-E4A1-45AC-A238-4FACF82AF6D0Q37313536-F56652A4-A4F1-4BED-8DBC-7709C3F90235Q41835663-84C2DC24-907F-4918-8579-735BDFA23977Q42194316-0964FA8B-C0E7-4BAD-8B2D-2E10B865B361Q52604152-3B382B98-DAC3-40F5-980A-3035B1836BCFQ58836858-7A15A3E9-E160-41DB-8BD4-3CB9F6A48663Q58836878-F343C7E7-768A-4677-9151-177CE49F85B3Q58836901-A833D99B-9CA1-4DA8-8A09-4F6F8336F344
P2860
Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of intravascular th ...... logs to activated endothelium.
@ast
Inhibition of intravascular th ...... logs to activated endothelium.
@en
type
label
Inhibition of intravascular th ...... logs to activated endothelium.
@ast
Inhibition of intravascular th ...... logs to activated endothelium.
@en
prefLabel
Inhibition of intravascular th ...... logs to activated endothelium.
@ast
Inhibition of intravascular th ...... logs to activated endothelium.
@en
P2093
P50
P1433
P1476
Inhibition of intravascular th ...... logs to activated endothelium.
@en
P2093
Daxin Chen
Edward Tuddenham
Geoff Kemball-Cook
Konstantinos Giannopoulos
Marilyn Moore
Robert Lechler
Zoe Webster
P304
P356
10.1182/BLOOD-2003-12-4365
P407
P577
2004-05-04T00:00:00Z